Studies in mice have shown an increase in COX-2 expression in mice with atherosclerosis and demonstrated that celecoxib, a selective COX-2 inhibitor, can prevent the evolution of atheroma lesions [45]. This evidence concerns the gene PTGS2 and atherosclerosis.